Cited by 84Bariatric Surgery and OutcomesCancer Risks and FactorsEsophageal Cancer Research and Treatment

Association of bariatric surgery with cancer incidence in patients with obesity and diabetes: long-term results from the Swedish obese subjects study

Open access
Sjöholm, Kajsa, Carlsson, Lena M.S., Svensson, Per-Arne, Andersson-Assarsson, Johanna C., Kristensson, Felipe, Jacobson, Peter, Peltonen, Markku, Taube, Magdalena·2022·Diabetes Care

Published version of a preprint

Abstract

OBJECTIVE: Obesity and type 2 diabetes are associated with serious adverse health effects, including cancer. Although bariatric surgery has been shown to reduce cancer risk in patients with obesity, the effect of bariatric surgery on cancer risk in patients with obesity and diabetes is less studied. We therefore examined the long-term incidence of cancer after bariatric surgery and usual care in patients with obesity and diabetes in the matched prospective Swedish Obese Subjects (SOS) study. RESEARCH DESIGN AND METHODS: The SOS study examines long-term outcomes following bariatric surgery or usual care. The current analysis includes 701 patients with obesity and type 2 diabetes at baseline, 393 of whom underwent bariatric surgery and 308 who received conventional obesity treatment. Information on cancer events was obtained from the Swedish National Cancer Register. Median follow-up time was 21.3 years (interquartile range 17.6-24.8 years, maximum 30.7 years). RESULTS: During follow-up, the incidence rate for first-time cancer was 9.1 per 1,000 person-years (95% CI 7.2-11.5) in patients with obesity and diabetes treated with bariatric surgery and 14.1 per 1,000 person-years (95% CI 11.2-17.7) in patients treated with usual obesity care (adjusted hazard ratio 0.63 [95% CI 0.44-0.89], P = 0.008). Moreover, surgery was associated with reduced cancer incidence in women (0.58 [0.38-0.90], P = 0.016), although the sex-treatment interaction was nonsignificant (P = 0.630). In addition, diabetes remission at the 10-year follow-up was associated with reduced cancer incidence (0.40 [0.22-0.74], P = 0.003). CONCLUSIONS: These results suggest that bariatric surgery prevents cancer in patients with obesity and diabetes and that durable diabetes remission is associated with reduced cancer risk.

Integrity signals

Registry

Crossref · 10.2337/dc21-1335

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Many prospective studies have shown that bariatric surgery induces stable weight loss, remission of T2D, improvement in cardiovascular risk, and a reduction in cancer (including liver cancer) risk.

    “Many prospective studies have shown that bariatric surgery induces stable weight loss, remission of T2D, 436 improvement in cardiovascular risk, 437 and a reduction in cancer (including liver cancer) risk.”
  • Studies have been limited by small sample sizes in combination therapy subgroups and trials have not consistently shown benefit for the combination of SGLT2is and GLP-1RAs on cardiovascular and kidney outcomes.

    “Studies have been limited by small sample sizes in combination therapy subgroups and trials have not consistently shown benefit for the combination of SGLT2is and GLP-1RAs on cardiovascular and kidney outcomes.73,112”

    From Diagnosis and Treatment of Type 2 Diabetes in Adults (2025) · cites this paper as [112]

  • Expected benefits of metabolic surgery include improved quality of life, reduced cardiovascular events, and decreased risk of hepatocellular, colorectal, pancreatic, gallbladder, breast, endometrial, and ovarian cancers.

    “In addition to weight reduction and decreased glycemia (with diabetes remission in some patients), expected benefits of metabolic surgery include improved quality of life, reduced cardiovascular events, and decreased risk of hepatocellular, colorectal, pancreatic, gallbladder, breast, endometrial, and ovarian cancers.14,123–126”

    From Diagnosis and Treatment of Type 2 Diabetes in Adults (2025) · cites this paper as [125]

Cites

2 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sjöholm, K., Carlsson, L. M. S., Svensson, P.-A., Andersson-Assarsson, J. C., Kristensson, F., Jacobson, P., Peltonen, M., & Taube, M.
Affiliations
  • University of Gothenburg (SE)
  • Department of Molecular and Clinical medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
  • Karolinska Institutet (SE)
Corresponding author
Taube, Magdalena
Venue
Diabetes Care
Published
2021-11-19
Volume
45
Issue
2
Pages
444-450
ISSN
0149-5992 (ISSN-L)
OpenAlex
W3214007678
Cited by
84
References
42
Citations by year
2026: 12 · 2025: 20 · 2024: 20 · 2023: 18 · 2022: 14
FWCI
12.20
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
Funders
Novo Nordisk Fonden (NNF 19OC0057184)
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
  • Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
Keywords
bariatric surgery, cancer incidence, obesity, type 2 diabetes, diabetes remission, cancer risk reduction, Swedish Obese Subjects study, sex differences in cancer risk
MeSH terms
Diabetes Mellitus, Type 2, Female, Humans, Neoplasms, Obesity, Prospective Studies, Sweden, Incidence, Bariatric Surgery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review